Dhanuka Agritech (507717) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
9 Jul, 2026Executive summary
Leadership transition with Mr. R.G. Agarwal stepping down as Chairman, succeeded by Mr. M.K. Dhanuka, and Mr. Rahul Dhanuka elevated to Managing Director; Mr. Agarwal continues as Chairman Emeritus.
Revenue from operations grew 33.74% year-over-year to INR 493.58 crores in Q1 FY25, driven by strong demand and new product launches.
EBITDA increased 64.46% year-over-year to INR 71.72 crores, and PAT rose 48.45% to INR 48.9 crores, reflecting improved profitability.
Board approved a buyback of up to 500,000 equity shares at INR 2,000 per share, totaling up to INR 100 crores.
Major board restructuring and succession planning completed, with additional management changes and the only subsidiary struck off in July 2024.
Financial highlights
Q1 FY25 revenue from operations at INR 493.58 crores, up 33.74% year-over-year.
EBITDA at INR 71.72 crores, up 64.46% year-over-year.
Profit after tax at INR 48.9 crores, up 48.45% year-over-year.
Basic and diluted EPS for the quarter were INR 10.73, compared to INR 7.23 in Q1 FY24.
Gross profit margin improved to 34.66% from 32.82% year-over-year.
Outlook and guidance
FY25 revenue growth guidance upgraded to 18%-20%.
Double-digit revenue growth (over 20%) expected for FY2024-25.
EBITDA margin guidance at approximately 18% for the full year.
Q2 expected to see lower double-digit growth due to sales returns and herbicide demand normalization.
Full-year EBITDA and gross margin expected to decline by around 100 basis points due to normalization from last year’s exceptional margins and negative EBITDA from Dahej plant.
Latest events from Dhanuka Agritech
- Q2 FY25 saw strong profit growth, margin expansion, and a major share buyback.507717
Q2 24/259 Jul 2026 - Q3 FY25 saw strong growth, margin gains, global expansion, and major buyback activity.507717
Q3 24/258 Jul 2026 - Record revenue, global expansion, and share buyback with double-digit growth guided for FY 2026.507717
Q4 24/258 Jul 2026 - Acquisition of two Bayer fungicides expands global reach, revenue, and cost efficiency.507717
M&A Announcement19 Jun 2026 - Q4 saw 9.35% revenue growth, record margins, and a ₹70 crore buyback with global expansion plans.507717
Q4 25/2622 May 2026 - Revenue and profit declined in Q3, but new launches and Dahej ramp-up support future growth.507717
Q3 25/265 Feb 2026 - Q2 FY26 revenue and profit fell YoY on weather and regulatory headwinds; outlook is flat.507717
Q2 25/2614 Dec 2025 - Q1 FY26 revenue up 7% YoY, with improved margins and strong product launches despite headwinds.507717
Q1 25/2616 Nov 2025